Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor.

European heart journal - 7 May 2024

Pedicino Daniela, Volpe Massimo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Genetic Predisposition to Disease
Share to Heart Disease Risk Factors
Share to Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA, Small Interfering

Source

Identifiers

PMID: 38437638
DOI: 10.1093/eurheartj/ehae118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor.PMID 38437638Read ↗

One-shot, one cure with genome editing for dyslipidemia.Semantic proximity Read ↗

Gene editing in common cardiovascular diseasesSemantic proximity Read ↗

Genome Editing Technology: A New Frontier for the Treatment and Prevention of Cardiovascular DiseasesSemantic proximity Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

Advances in nucleic acid-targeted therapies for cardiovascular disease preventionSemantic proximity Read ↗

Updates in Small Interfering RNA for the Treatment of DyslipidemiasSemantic proximity Read ↗

Almost daily I have read about advances in genetics. Will this translate into better treatments for heart disease?Semantic proximity Read ↗

A genomic revolution for cardiovascular disease-a progress report at five years.Semantic proximity Read ↗

Moving toward genome-editing therapies for cardiovascular diseasesSemantic proximity Read ↗

New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome EditingSemantic proximity Read ↗

A new dawn for managing dyslipidemias: The era of rna-based therapiesSemantic proximity Read ↗

A New Class of Medicines through DNA EditingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.